Nursing care
Why BNP rises in heart failure and how the nurse reads the trend
Written and reviewed by Dana Whitfield, RN, MSN · 3 min read · Updated October 2026
Short answer
BNP is a hormone released mainly by ventricular muscle when it is stretched by excess volume or pressure. It promotes sodium and water excretion and relaxes blood vessels to ease the heart's load. In heart failure the ventricles are chronically overstretched, so BNP rises, and a rising trend usually signals worsening congestion that the nurse correlates with assessment findings.
Stretch is the signal that releases BNP
Ventricular muscle cells respond to wall stretch, raised filling pressure and dilation by producing a precursor called proBNP. It is split into active BNP and an inactive fragment, NT-proBNP, both of which enter the blood and can be measured. MedlinePlus describes the trigger simply: the heart releases more when it is working harder to pump.
In heart failure the ventricles fill under high pressure and stay stretched, so release continues. The greater the stretch, the higher the level tends to be, and MedlinePlus notes that higher values generally go with more severe heart failure. This direct link to wall stress is why BNP tracks fluid overload so closely.
What BNP does once it is released
BNP acts as the heart's own counterweight to fluid retention. It signals the kidneys to excrete sodium and water and relaxes blood vessels, reducing the volume and resistance the heart must work against. It also opposes parts of the renin-angiotensin-aldosterone system that drive fluid retention.
In heart failure this protective response is overwhelmed by competing signals that hold on to salt and water, so congestion still develops. Understanding BNP as a compensatory hormone explains why levels are high when the client is most overloaded and fall as diuresis and other treatment reduce ventricular stretch.
What else changes the level
BNP is not specific to heart failure. MedlinePlus lists kidney failure, valve and other heart muscle disease, pulmonary embolism and pulmonary hypertension among other causes of raised values. Normal ranges also vary with age and sex, so the laboratory reference and the prescriber's interpretation matter.
Obesity is associated with lower levels, so an overloaded client with obesity may have a misleadingly reassuring result. Sacubitril-valsartan inhibits the enzyme that breaks down BNP, which can raise BNP itself; NT-proBNP is not cleared by that enzyme and is often preferred for monitoring in clients on this medicine. Note which test was ordered before comparing results.
Tie the number to fluid status and findings
A BNP value is most useful alongside the bedside picture. When a level rises, look for matching signs: weight gain over days, increased oedema, jugular venous distension, crackles, orthopnea, reduced urine output relative to intake and falling activity tolerance. Consistent findings strengthen the case for worsening congestion and the need to report.
When diuresis is working, BNP often trends down along with weight and symptoms. A falling value with worsening breathing still needs escalation, because the number does not override the assessment. Compare like with like: same test type, similar timing, and results interpreted against kidney function and recent medication changes.
Work a hypothetical scenario
Imagine a hypothetical client with heart failure whose BNP has risen markedly since last month. Weight is up compared with three days ago, ankles are more swollen and they now need extra pillows. Options are to repeat the test because the number seems high, record it as expected for heart failure, or report rising BNP with matching signs of fluid overload.
Reporting with the supporting findings is strongest because the laboratory trend and the assessment agree, indicating worsening congestion. Repeating the test delays care without a reason to doubt it, and labelling it expected ignores the change from baseline. Continue monitoring weight, lung sounds, intake and output while the plan is reviewed.
Sources and further reading
MedlinePlus: Natriuretic Peptide Tests (BNP, NT-proBNP). BNP release when the heart works harder, vessel and kidney actions, other causes of raised levels, obesity effect and severity correlation.
Natriuretic peptides in chronic heart failure (PMC). Renal impairment and obesity as confounders, sacubitril-valsartan effects on BNP versus NT-proBNP, and serial monitoring.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our dosage calculation and lab values practice questions are the closest set to what this page covers.
Common questions
What physically triggers BNP release?
Stretch of the ventricular wall from excess volume or pressure. Ventricular muscle cells respond by producing proBNP, which splits into active BNP and inactive NT-proBNP.
Can a client have heart failure with a normal BNP?
It is less likely, but obesity can lower levels and results must be read with the clinical picture. A normal value does not override clear signs of overload.
Why might NT-proBNP be preferred for a client taking sacubitril-valsartan?
Sacubitril blocks the enzyme that breaks down BNP, which can raise BNP without worsening heart failure. NT-proBNP is not cleared by that enzyme, so trends are easier to interpret.
More on dosage calculation and lab values